Table 2.

Complement and anti-complement levels in gestational diabetes (GDM) and control women.

	Control (n = 16)	GDM (n = 34)	Unadjusted	Adjusted
	Mean (SD)	Mean (SD)	p-value	p-value
Anti-Complement C2 (µg/ml)	6.9 (3.4)	7.1 (4.6)	0.89	0.29
Anti-Complement C4b (µg/ml)	12.8 (3.1)	13.3 (2.9)	0.64	0.28
Anti-Complement C5 (µg/ml)	41.2 (6.1)	40.3 (5.8)	0.62	0.91
Anti-Complement C5a (µg/ml)	0.7 (0.5)	0.8 (0.5)	0.82	0.45
Anti-Complement Factor-D (µg/ml)	2267.0 (403.0)	2148.0 (404.0)	0.33	0.22
Anti-Mannose-binding lectin (µg/ml)	2.9 (2.7)	2.5 (2.6)	0.62	0.63
Anti-complement factor-1 (µg/ml)	36.1 (6.9)	37.0 (9.7)	0.5	0.33
Complement- C1q (µg/ml)	82.4 (18.9)	80.0 (13.9)	0.63	0.62
Complement C3 (µg/ml)	162.0 (56.0)	279.0 (126.0)	0.001	0.04
Complement C3b/iC3b (µg/ml)	373.0 (270.0)	666.0 (561.0)	0.06	0.12
Complement C4 (µg/ml)	487.0 (105.0)	550.0 (96.0)	0.05	0.08
Factor-B (µg/ml)	262.0 (65.0)	293.0 (55.0)	0.08	0.19
Factor-H (µg/ml)	310.0 (66.0)	358.0 (57.0)	0.01	0.04
Properdin (µg/ml)	27.6 (6.7)	29.9 (7.7)	0.3	0.07